Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 0.89% and Operating profit at 4.55% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Capital Employed (avg) of 4.68% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 0.89% and Operating profit at 4.55% over the last 5 years
3
The company has declared Negative results for the last 3 consecutive quarters
4
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 16,798 Million (Small Cap)
12.00
NA
0.07%
0.83
6.30%
0.94
Revenue and Profits:
Net Sales:
8,548 Million
(Quarterly Results - Jun 2025)
Net Profit:
383 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.55%
0%
2.55%
6 Months
26.58%
0%
26.58%
1 Year
20.09%
0%
20.09%
2 Years
-30.87%
0%
-30.87%
3 Years
13.08%
0%
13.08%
4 Years
0.9%
0%
0.9%
5 Years
-9.94%
0%
-9.94%
Seed Co., Ltd. /7743/ for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.89%
EBIT Growth (5y)
4.55%
EBIT to Interest (avg)
6.33
Debt to EBITDA (avg)
3.38
Net Debt to Equity (avg)
0.77
Sales to Capital Employed (avg)
0.92
Tax Ratio
17.04%
Dividend Payout Ratio
41.56%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.68%
ROE (avg)
8.65%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
0.74
EV to EBIT
17.45
EV to EBITDA
5.51
EV to Capital Employed
0.85
EV to Sales
0.82
PEG Ratio
NA
Dividend Yield
0.09%
ROCE (Latest)
4.90%
ROE (Latest)
6.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
8,547.70
8,043.10
6.27%
Operating Profit (PBDIT) excl Other Income
1,402.90
1,181.40
18.75%
Interest
98.00
90.50
8.29%
Exceptional Items
0.20
-8.80
102.27%
Consolidate Net Profit
383.10
255.50
49.94%
Operating Profit Margin (Excl OI)
73.80%
36.60%
3.72%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 6.27% vs -3.79% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 49.94% vs -10.88% in Mar 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
33,231.60
32,396.80
2.58%
Operating Profit (PBDIT) excl Other Income
4,947.00
4,880.50
1.36%
Interest
337.50
213.40
58.15%
Exceptional Items
-8.70
-30.30
71.29%
Consolidate Net Profit
1,100.50
1,963.50
-43.95%
Operating Profit Margin (Excl OI)
47.00%
63.30%
-1.63%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 2.58% vs 5.89% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -43.95% vs 656.39% in Mar 2024
About Seed Co., Ltd. /7743/ 
Seed Co., Ltd. /7743/
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






